Novartis secures EC approval for up-titration of Cosentyx for ankylosing spondylitis
Cosentyx is supported by sufficient clinical evidence, including 5-year data across PsO, PsA and AS, along with data…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Oct 19
Cosentyx is supported by sufficient clinical evidence, including 5-year data across PsO, PsA and AS, along with data…
About 2,000 people die in the UK each year from taking powerful painkillers - and overprescriptions are a…
23 Oct 19
Biorphen avoids the compounding and reduces the risks for unsafe injection practices, medication administration errors, sterility breaches, and…
18 Oct 19
The study results demonstrated that Xofluza has reduced the time required to improve from flu symptoms compared to…
10 Oct 19
In 2015, a jury found that J&J has failed to warn of the risk of gynecomastia, and awarded…
09 Oct 19
Gilead Sciences has filed the NDA for filgotinib based on the data from the Phase 3 FINCH clinical…
09 Oct 19
Clinuvel has designed SCENESSE to increase pain -free light exposure in adult patients with phototoxic reactions from erythropoietic…
30 Sep 19
GPA and MPA are two different types of ANCA-associated vasculitis (AAV) that primarily affects small blood vessels of…
25 Sep 19
Jynneos does not contain smallpox or monkeypox causing viruses, and is made from a vaccinia virus that is…
24 Sep 19
Vitrakvi is used for treating of adult and paediatric patients with solid tumours presenting Neurotrophic Tyrosine Receptor Kinase…